Acceptability of medical abortion with methotrexate and misoprostol

Mitchell D Creinin, Maureen Park

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A clinical trial of efficacy of methotrexate and misoprostol for abortion was performed involving 86 women requesting and abortion at < 56 days gestation. An acceptability evaluation was included in the design of the trial. Subjects were questioned before the study about their reasons for choosing a medical abortion and past experience with surgical abortion. After the study was completed, the women were questioned about their medical abortion experience. All questions were asked in an open-ended manner. Eighty-five of 86 (99%) patients completed both questionnaires. The most common reason cited as to why women chose to have a medical abortion was to avoid some aspect of the surgery (48%). Forty-one (48%) women had experienced a surgical abortion; 49% of these women chose to have a medical abortion because of a "bad" past experience related to the surgical procedure. Upon completion of the study, 67 (79%) patients stated the medical abortion was a good experience, 12 (14%) a bad experience, and 6 (7%) had a neutral response. When asked what method they would choose if they were to have another abortion, 89% would choose this method of medical abortion rather than a surgical abortion. In women who choose to participate in a clinical research trial, methotrexate and vaginal misoprostol are an acceptable and desirable method of abortion.

Original languageEnglish (US)
Pages (from-to)41-44
Number of pages4
JournalContraception
Volume52
Issue number1
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Misoprostol
Methotrexate
Clinical Trials
Pregnancy
Research

Keywords

  • acceptability
  • medical abortion
  • methotrexate
  • misoprostol

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Medicine(all)

Cite this

Acceptability of medical abortion with methotrexate and misoprostol. / Creinin, Mitchell D; Park, Maureen.

In: Contraception, Vol. 52, No. 1, 1995, p. 41-44.

Research output: Contribution to journalArticle

@article{abd1405fbf224fe6b26d8bb108798840,
title = "Acceptability of medical abortion with methotrexate and misoprostol",
abstract = "A clinical trial of efficacy of methotrexate and misoprostol for abortion was performed involving 86 women requesting and abortion at < 56 days gestation. An acceptability evaluation was included in the design of the trial. Subjects were questioned before the study about their reasons for choosing a medical abortion and past experience with surgical abortion. After the study was completed, the women were questioned about their medical abortion experience. All questions were asked in an open-ended manner. Eighty-five of 86 (99{\%}) patients completed both questionnaires. The most common reason cited as to why women chose to have a medical abortion was to avoid some aspect of the surgery (48{\%}). Forty-one (48{\%}) women had experienced a surgical abortion; 49{\%} of these women chose to have a medical abortion because of a {"}bad{"} past experience related to the surgical procedure. Upon completion of the study, 67 (79{\%}) patients stated the medical abortion was a good experience, 12 (14{\%}) a bad experience, and 6 (7{\%}) had a neutral response. When asked what method they would choose if they were to have another abortion, 89{\%} would choose this method of medical abortion rather than a surgical abortion. In women who choose to participate in a clinical research trial, methotrexate and vaginal misoprostol are an acceptable and desirable method of abortion.",
keywords = "acceptability, medical abortion, methotrexate, misoprostol",
author = "Creinin, {Mitchell D} and Maureen Park",
year = "1995",
doi = "10.1016/0010-7824(95)00122-Q",
language = "English (US)",
volume = "52",
pages = "41--44",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Acceptability of medical abortion with methotrexate and misoprostol

AU - Creinin, Mitchell D

AU - Park, Maureen

PY - 1995

Y1 - 1995

N2 - A clinical trial of efficacy of methotrexate and misoprostol for abortion was performed involving 86 women requesting and abortion at < 56 days gestation. An acceptability evaluation was included in the design of the trial. Subjects were questioned before the study about their reasons for choosing a medical abortion and past experience with surgical abortion. After the study was completed, the women were questioned about their medical abortion experience. All questions were asked in an open-ended manner. Eighty-five of 86 (99%) patients completed both questionnaires. The most common reason cited as to why women chose to have a medical abortion was to avoid some aspect of the surgery (48%). Forty-one (48%) women had experienced a surgical abortion; 49% of these women chose to have a medical abortion because of a "bad" past experience related to the surgical procedure. Upon completion of the study, 67 (79%) patients stated the medical abortion was a good experience, 12 (14%) a bad experience, and 6 (7%) had a neutral response. When asked what method they would choose if they were to have another abortion, 89% would choose this method of medical abortion rather than a surgical abortion. In women who choose to participate in a clinical research trial, methotrexate and vaginal misoprostol are an acceptable and desirable method of abortion.

AB - A clinical trial of efficacy of methotrexate and misoprostol for abortion was performed involving 86 women requesting and abortion at < 56 days gestation. An acceptability evaluation was included in the design of the trial. Subjects were questioned before the study about their reasons for choosing a medical abortion and past experience with surgical abortion. After the study was completed, the women were questioned about their medical abortion experience. All questions were asked in an open-ended manner. Eighty-five of 86 (99%) patients completed both questionnaires. The most common reason cited as to why women chose to have a medical abortion was to avoid some aspect of the surgery (48%). Forty-one (48%) women had experienced a surgical abortion; 49% of these women chose to have a medical abortion because of a "bad" past experience related to the surgical procedure. Upon completion of the study, 67 (79%) patients stated the medical abortion was a good experience, 12 (14%) a bad experience, and 6 (7%) had a neutral response. When asked what method they would choose if they were to have another abortion, 89% would choose this method of medical abortion rather than a surgical abortion. In women who choose to participate in a clinical research trial, methotrexate and vaginal misoprostol are an acceptable and desirable method of abortion.

KW - acceptability

KW - medical abortion

KW - methotrexate

KW - misoprostol

UR - http://www.scopus.com/inward/record.url?scp=0029067893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029067893&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(95)00122-Q

DO - 10.1016/0010-7824(95)00122-Q

M3 - Article

C2 - 8521713

AN - SCOPUS:0029067893

VL - 52

SP - 41

EP - 44

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 1

ER -